Piper!「🦑」

💥BREAKING: New York Times article, published today, concludes that Adam Back, a 55-year-old British computer scientist and cryptographer, is Satoshi Nakamoto.

Most people picture MDMA therapy as a capsule, a long afternoon on a couch, and a therapist taking notes for six hours. That picture is already outdated. In the underground facilitation scene in Austin, which has quietly become the epicenter of psychedelic work in the US, a different protocol is taking hold. Instead of swallowing the medicine and waiting, facilitators are administering MDMA intramuscularly, a small injection into the shoulder or buttocks, the same route used for B12 or testosterone. With oral MDMA, onset can take up to 45 minutes. You dose, you wait, you wonder if it's working, and somewhere in that window the medicine finally arrives. IM changes that. The experience begins to unfold in just 5 to 10 minutes. And there's something else worth naming: it appears to be much softer on the nervous system. None of the jittery, teeth-clenching come-up that oral MDMA is known for. You slip into the experience without the turbulence, which matters enormously for people who are already carrying trauma into the room. Sessions run 3 to 4 hours instead of 6, long enough for real work, short enough that integration doesn't get pushed into the middle of the night. Dosing runs at about 80% of the oral dose. If your standard oral dose is 120 mg, you'd start IM around 100 mg, with the option of a 60 to 80 mg booster about an hour in. A serious caveat: source quality is non-negotiable here. You are putting a substance directly into muscle tissue, bypassing every filter your gut would normally provide. Adulterants, incorrect dosing, or sloppy preparation carry consequences that oral simply does not. This is not a protocol for the curious or the casual. It belongs in the hands of experienced facilitators working with verified material, full stop. None of this is FDA-approved. It's happening in private homes, run by facilitators who've decided the oral protocol MAPS/Lykos spent two decades pushing through the FDA isn't actually the optimal way to do this work. What does it say about the field that the most interesting innovations in MDMA therapy are happening entirely outside the regulatory pathway that was supposed to legitimize it?